News

Q&A: Why does a child-centered response to COVID-19 matter?

EdNC spoke with Dr. Sallie Permar, director of the Children’s Health and Discovery Initiative at Duke University Medical School, about the coronavirus pandemic’s impacts on children and children’s role in policy and research as North Carolina reopens. Dr. Permar, who is also a professor of pediatrics, immunology, and molecular genetics and microbiology, says child-centered solutions will be important in overcoming the pandemic.

Faculty Spotlight: Michael J. Smith, MD

In this week’s Faculty Spotlight, Michael J. Smith, MD, MSCE, talks to us about his clinical responsibilities, including medical directorship of the pediatric infectious diseases clinic and the pediatric antimicrobial stewardship program. He also shares how he’s adapting at work and at home to treat patients and care for his own children during the age of COVID-19. He believes that collaboration and building relationships with faculty in other divisions has been an essential strategy in adapting to this time of uncertainty.

Cohen-Wolkowiez and Permar honored with Distinguished Professorships

Michael Cohen-Wolkowiez, MD, PhD, professor of pediatrics in the Divisions of Infectious Diseases and Quantitative Sciences, and Sallie Permar, MD, PhD, professor of pediatrics in the Division of Infectious Diseases, are among nine faculty who have been recognized with Distinguished Professorships from the School of Medicine in 2020.

Children and COVID-19

A curious feature of the new coronavirus is that it rarely causes severe symptoms in children

Surana receives 2019 Hartwell Individual Biomedical Research Award

Neeraj (“Neil”) Surana, MD, PhD, an assistant professor of pediatrics, immunology, and molecular genetics and microbiology in the School of Medicine, is one of 12 recipients of the 2019 Hartwell Individual Biomedical Research Award, according to The Hartwell Foundation.

A universal flu vaccine in their sights

Coronavirus isn't the only deadly virus making the rounds. Duke researchers have been tapped by the federal government to work on a vaccine that could save thousands of lives struck down by flu.